Rabab M. Soliman , Nadia M. Mostafa , Yasmin M. Fayez , Hany H. Monir , Yasmin Rostom
{"title":"绿色分光光度法应用于治疗普通感冒和 COVID-19 症状的三级混合物。","authors":"Rabab M. Soliman , Nadia M. Mostafa , Yasmin M. Fayez , Hany H. Monir , Yasmin Rostom","doi":"10.1016/j.saa.2024.125381","DOIUrl":null,"url":null,"abstract":"<div><div>Recently, cold and cough dosage forms have gained significant attention due to their use in the supportive protocols for managing COVID-19 symptoms. In this study, a pharmaceutical formulation containing Paracetamol (PAR), Guaifenesin (GUA), and Phenylephrine hydrochloride (PHE) was investigated for spectral resolution and quantification using advanced spectrophotometric methods. The spectra of these components were significantly overlapped and present in their combined tablet in a challenging ratio of 250:100:5 for PAR, GUA, and PHE, respectively. The established approaches were employed for the simultaneous determination of these drugs in their pharmaceutical formulation without interference from matrix excipients. The study involved various manipulation steps, allowing each component in the combination to be analyzed by more than one approach. Integrating these methods with smart mathematical techniques, the issue of spectral data overlap was resolved without the need for preliminary separation steps. The developed methods are dual wavelength, first derivative, derivative ratio, ratio difference, constant center coupled with spectrum subtraction, and constant multiplication paired with spectrum subtraction. The proposed methods were linear over the concentration range of 3.0–35.0 μg/mL for GUA and 3.0–30.0 μg/mL for PHE. While the PAR ranges for the first derivative and constant multiplication methods were 2.5–35.0 μg/mL and 2.5–25.0 μg/mL, respectively. Excellent linearity of the suggested methods was demonstrated by the high correlation coefficients (R2), ≥ 0.9998 for all the tested compounds. These methodologies were validated according to ICH guidelines. Validation results demonstrated excellent accuracy, with recovery percentages ranging from 98 to 102 %, and precision, with RSD values less than 2 %. The obtained results were statistically compared with the official ones using F-test, Student’s <em>t</em>-test, and one-way ANOVA, revealing no significant differences. The proposed methods are accurate, green, smart, fast, and cost-effective. Their compliance with Green Analytical Chemistry principles was evaluated and compared to a published method using various tools to enable a more holistic evaluation from different perspectives. The promising results revealed that the investigated methods are superior green alternatives for routine analysis of the cited drugs in laboratories with limited resources and without access to expensive instruments.</div></div>","PeriodicalId":433,"journal":{"name":"Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy","volume":"327 ","pages":"Article 125381"},"PeriodicalIF":4.3000,"publicationDate":"2024-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Green spectrophotometric approaches applied to tertiary mixture for management of common cold and COVID-19 symptoms\",\"authors\":\"Rabab M. Soliman , Nadia M. Mostafa , Yasmin M. Fayez , Hany H. Monir , Yasmin Rostom\",\"doi\":\"10.1016/j.saa.2024.125381\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>Recently, cold and cough dosage forms have gained significant attention due to their use in the supportive protocols for managing COVID-19 symptoms. In this study, a pharmaceutical formulation containing Paracetamol (PAR), Guaifenesin (GUA), and Phenylephrine hydrochloride (PHE) was investigated for spectral resolution and quantification using advanced spectrophotometric methods. The spectra of these components were significantly overlapped and present in their combined tablet in a challenging ratio of 250:100:5 for PAR, GUA, and PHE, respectively. The established approaches were employed for the simultaneous determination of these drugs in their pharmaceutical formulation without interference from matrix excipients. The study involved various manipulation steps, allowing each component in the combination to be analyzed by more than one approach. Integrating these methods with smart mathematical techniques, the issue of spectral data overlap was resolved without the need for preliminary separation steps. The developed methods are dual wavelength, first derivative, derivative ratio, ratio difference, constant center coupled with spectrum subtraction, and constant multiplication paired with spectrum subtraction. The proposed methods were linear over the concentration range of 3.0–35.0 μg/mL for GUA and 3.0–30.0 μg/mL for PHE. While the PAR ranges for the first derivative and constant multiplication methods were 2.5–35.0 μg/mL and 2.5–25.0 μg/mL, respectively. Excellent linearity of the suggested methods was demonstrated by the high correlation coefficients (R2), ≥ 0.9998 for all the tested compounds. These methodologies were validated according to ICH guidelines. Validation results demonstrated excellent accuracy, with recovery percentages ranging from 98 to 102 %, and precision, with RSD values less than 2 %. The obtained results were statistically compared with the official ones using F-test, Student’s <em>t</em>-test, and one-way ANOVA, revealing no significant differences. The proposed methods are accurate, green, smart, fast, and cost-effective. Their compliance with Green Analytical Chemistry principles was evaluated and compared to a published method using various tools to enable a more holistic evaluation from different perspectives. The promising results revealed that the investigated methods are superior green alternatives for routine analysis of the cited drugs in laboratories with limited resources and without access to expensive instruments.</div></div>\",\"PeriodicalId\":433,\"journal\":{\"name\":\"Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy\",\"volume\":\"327 \",\"pages\":\"Article 125381\"},\"PeriodicalIF\":4.3000,\"publicationDate\":\"2024-11-02\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy\",\"FirstCategoryId\":\"92\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1386142524015476\",\"RegionNum\":2,\"RegionCategory\":\"化学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"SPECTROSCOPY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy","FirstCategoryId":"92","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1386142524015476","RegionNum":2,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"SPECTROSCOPY","Score":null,"Total":0}
引用次数: 0
摘要
最近,感冒和咳嗽剂型因其在控制 COVID-19 症状的辅助方案中的应用而备受关注。本研究采用先进的分光光度法,对含有扑热息痛(PAR)、愈创木酚(GUA)和盐酸去氧肾上腺素(PHE)的药物制剂进行了光谱分辨率和定量研究。这些成分的光谱明显重叠,在它们的组合片剂中,PAR、GUA 和 PHE 的挑战性比例分别为 250:100:5。在不受基质辅料干扰的情况下,采用既定方法同时测定了药物制剂中的这些药物。该研究涉及多个操作步骤,允许用一种以上的方法对组合物中的每种成分进行分析。通过将这些方法与智能数学技术相结合,解决了光谱数据重叠的问题,而无需进行初步分离步骤。所开发的方法包括双波长法、一阶导数法、导数比值法、比值差法、常量中心与光谱减法结合法以及常量乘法与光谱减法结合法。所提出的方法在 GUA 浓度为 3.0-35.0 μg/mL 和 PHE 浓度为 3.0-30.0 μg/mL 的范围内呈线性关系。而一阶导数法和常数倍增法的 PAR 范围分别为 2.5-35.0 μg/mL 和 2.5-25.0 μg/mL。所有受测化合物的相关系数(R2)均≥ 0.9998,这表明所建议的方法具有良好的线性关系。根据 ICH 指南对这些方法进行了验证。验证结果表明,这些方法的准确度和精密度都非常高,回收率在 98% 到 102% 之间,RSD 值小于 2%。使用 F 检验、学生 t 检验和单因素方差分析对所获得的结果与官方结果进行了统计比较,结果显示两者之间没有显著差异。所提出的方法准确、绿色、智能、快速、经济。使用各种工具对这些方法是否符合绿色分析化学原则进行了评估,并与已公布的方法进行了比较,以便从不同角度进行更全面的评估。令人鼓舞的结果表明,所研究的方法是在资源有限且无法获得昂贵仪器的实验室中对上述药物进行常规分析的优越绿色替代方法。
Green spectrophotometric approaches applied to tertiary mixture for management of common cold and COVID-19 symptoms
Recently, cold and cough dosage forms have gained significant attention due to their use in the supportive protocols for managing COVID-19 symptoms. In this study, a pharmaceutical formulation containing Paracetamol (PAR), Guaifenesin (GUA), and Phenylephrine hydrochloride (PHE) was investigated for spectral resolution and quantification using advanced spectrophotometric methods. The spectra of these components were significantly overlapped and present in their combined tablet in a challenging ratio of 250:100:5 for PAR, GUA, and PHE, respectively. The established approaches were employed for the simultaneous determination of these drugs in their pharmaceutical formulation without interference from matrix excipients. The study involved various manipulation steps, allowing each component in the combination to be analyzed by more than one approach. Integrating these methods with smart mathematical techniques, the issue of spectral data overlap was resolved without the need for preliminary separation steps. The developed methods are dual wavelength, first derivative, derivative ratio, ratio difference, constant center coupled with spectrum subtraction, and constant multiplication paired with spectrum subtraction. The proposed methods were linear over the concentration range of 3.0–35.0 μg/mL for GUA and 3.0–30.0 μg/mL for PHE. While the PAR ranges for the first derivative and constant multiplication methods were 2.5–35.0 μg/mL and 2.5–25.0 μg/mL, respectively. Excellent linearity of the suggested methods was demonstrated by the high correlation coefficients (R2), ≥ 0.9998 for all the tested compounds. These methodologies were validated according to ICH guidelines. Validation results demonstrated excellent accuracy, with recovery percentages ranging from 98 to 102 %, and precision, with RSD values less than 2 %. The obtained results were statistically compared with the official ones using F-test, Student’s t-test, and one-way ANOVA, revealing no significant differences. The proposed methods are accurate, green, smart, fast, and cost-effective. Their compliance with Green Analytical Chemistry principles was evaluated and compared to a published method using various tools to enable a more holistic evaluation from different perspectives. The promising results revealed that the investigated methods are superior green alternatives for routine analysis of the cited drugs in laboratories with limited resources and without access to expensive instruments.
期刊介绍:
Spectrochimica Acta, Part A: Molecular and Biomolecular Spectroscopy (SAA) is an interdisciplinary journal which spans from basic to applied aspects of optical spectroscopy in chemistry, medicine, biology, and materials science.
The journal publishes original scientific papers that feature high-quality spectroscopic data and analysis. From the broad range of optical spectroscopies, the emphasis is on electronic, vibrational or rotational spectra of molecules, rather than on spectroscopy based on magnetic moments.
Criteria for publication in SAA are novelty, uniqueness, and outstanding quality. Routine applications of spectroscopic techniques and computational methods are not appropriate.
Topics of particular interest of Spectrochimica Acta Part A include, but are not limited to:
Spectroscopy and dynamics of bioanalytical, biomedical, environmental, and atmospheric sciences,
Novel experimental techniques or instrumentation for molecular spectroscopy,
Novel theoretical and computational methods,
Novel applications in photochemistry and photobiology,
Novel interpretational approaches as well as advances in data analysis based on electronic or vibrational spectroscopy.